AmKor Pharma

AmKor Pharma, Inc. (AmKor) is a biopharmaceutical company with a clinical stage focus on products that treat the body’s response to injury. We operate our business with minimal infrastructure, contracting out most activities to contract research organizations, manufacturers and testing labs. Reducing infrastructure costs reduces financial risk and is practical for developmental stages of pharmaceutical research.

Spotlight

Our lead product is Neu2000, a multi-mechanism neuroprotectant compound being developed initially for the treatment of ischemic stroke and cardiac arrest.